Did Byron Donalds sell Regeneron Pharmaceuticals stock?

Common questions

Did Byron Donalds sell Regeneron Pharmaceuticals stock?

Yes. Byron Donalds disclosed 2 sales of Regeneron Pharmaceuticals (REGN) stock on Apr 10, 2025, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.

How big were Byron Donalds's Regeneron Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $2K-$30K.

Did Byron Donalds make these Regeneron Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Byron Donalds still own Regeneron Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Byron Donalds report these trades?

The latest filing is dated May 24, 2025. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.